OnKure Therapeutics Future Growth
Future criteria checks 2/6
OnKure Therapeutics is forecast to grow earnings and revenue by 50.1% and 80.8% per annum respectively while EPS is expected to grow by 53.6% per annum.
Key information
50.1%
Earnings growth rate
53.6%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 80.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Nov 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1 | -10 | N/A | N/A | 2 |
| 12/31/2025 | 1 | -42 | N/A | N/A | 2 |
| 12/31/2024 | N/A | -32 | N/A | N/A | 2 |
| 9/30/2024 | N/A | -45 | -35 | -35 | N/A |
| 6/30/2024 | N/A | -42 | -36 | -36 | N/A |
| 3/31/2024 | N/A | -36 | -41 | -41 | N/A |
| 12/31/2023 | N/A | -35 | -35 | -35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OKUR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OKUR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OKUR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OKUR's revenue (80.8% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: OKUR's revenue (80.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OKUR's Return on Equity is forecast to be high in 3 years time